The Global Alliance for Chronic Diseases (GACD) funding call will focus on implementation research that takes a life course approach to the prevention and reduction of common non-communicable disease (NCD) risk factors in Low- and Middle-Income Countries (LMICs) and/or in populations facing conditions of vulnerability in High-Income Countries (HICs).
The GACD brings together national and international funding agencies to address NCDs in LMICs and in vulnerable populations in HICs.
A major focus of the GACD is collaboration, both for GACD member agencies as well as for the researchers who are funded through GACD programs.
The joint development and management of funding opportunities and research programs increases transparency, helps to draw on a much wider pool of expertise and maximises the members’ investments. The coordination of research priorities avoids the potential duplication of efforts and builds a critical mass in research areas where the need for evidence to inform policy, programs and practice is most urgent. The GACD’s capacity to foster research partnerships between institutions in high-income countries and LMICs enables knowledge sharing and capacity building.
Apply for funding
NHMRC is inviting investigators to submit applications for implementation research that takes a life course approach to the prevention and reduction of common NCD risk factors in Low- and Middle-Income Countries (LMICs) and/or in populations facing conditions of vulnerability in High-Income Countries (HICs). For Australia, vulnerable populations in HICs is limited to Aboriginal and Torres Strait Islander peoples.
The objective of the call is to support implementation research focused on addressing common NCD risk factors through interventions that reduce health risk and/or enhance positive health and lifestyle behaviours in young people, and/or in other vulnerable life course stages. Please note that NHMRC will only consider proposals relating to young people (10-24), which includes adolescents (ages 10-19) and youth (15-24). Full details of the aim, scope and assessment criteria of this call can be found on the GACD website.
Funding agencies involved in this call are:
- National Health and Medical Research Council (NHMRC), Australia
- São Paulo Research Foundation (FAPESP), Brazil
- Canadian Institutes of Health Research (CIHR)
- Research & Innovation DG, European Commission (EC)
- Indian Council of Medical Research (ICMR)
- Japan Agency for Medical Research and Development (AMED)
- South African Medical Research Council (SAMRC)
- Health Systems Research Institute (HSRI), Thailand
- Medical Research Council (MRC UK)
- National Institute for Health Research (NIHR)
- The Research Council of Norway (RCN)
- US National Institutes of Health (NIH)
This GACD funding call will be conducted in a two-stage application and assessment process consisting of an initial NHMRC peer review process, followed by the GACD Joint International Review.
- Applications submitted through both the GACD’s common submission portal and Sapphire
- NHMRC assesses eligibility of applications
- NHMRC allocates applications to independent peer reviewers
- NFFC list developed by peer reviewers.
- Non-NFFC applications reviewed by a Joint International Review Panel.
|30 November 2021||Applications open in GACD common submission portal|
|30 March 2022||Applications open in Sapphire|
|31 May 2022||Applications close in GACD common submission portal|
|17:00 ACT local time
2 June 2022
|Applications close in Sapphire|
|Early June to Late July 2022||Stage 1 review Not For Further Consideration (NFFC)|
|Mid-August to late October 2022
1 November 2022
|Stage 2 evaluation
GACD Joint International Review Panel meeting begins
|November 2022||GACD notifies NHMRC of applications deemed fundable by GACD review panel.
NHMRC eligibility check.
NHMRC assesses Australian budget component of eligible applications.
|February 2023*||Anticipated notification of outcomes|
*Date is indicative and subject to change.